Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

Knight SR. et al, (2020), BMJ, m3339 - m3339

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.

WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group None. et al, (2020), JAMA

Human plague: An old scourge that needs new answers.

Vallès X. et al, (2020), PLoS neglected tropical diseases, 14

Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.

Rojek AM. et al, (2020), BMC medicine, 18

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial.

Randremanana RV. et al, (2020), Trials, 21

Core Outcomes Set for Trials in People With Coronavirus Disease 2019.

Tong A. et al, (2020), Critical care medicine

International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019.

Evangelidis N. et al, (2020), Critical care medicine

Early clinical characteristics of Covid-19: scoping review

Manoharan L. et al, (2020)

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

Knight SR. et al, (2020)

A minimal common outcome measure set for COVID-19 clinical research

Marshall JC. et al, (2020), The Lancet Infectious Diseases, 20, e192 - e197

Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials

Landray M. and Horby P., (2020), Trials

ISARIC COVID-19 Clinical Data Report: 8 June 2020

Hall M. et al, (2020)

Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.

RECOVERY Collaborative Group None. et al, (2020), The New England journal of medicine

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Landray M. et al, (2020), New England Journal of Medicine

Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.

Horby P. et al, (2020)

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis.

Xu J. et al, (2020), Frontiers of medicine

Global outbreak research: harmony not hegemony

Akhvlediani T. et al, (2020), The Lancet Infectious Diseases, 20, 770 - 772

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report

Horby P. et al, (2020)

Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort

Hoa LNM. et al, (2020), The Journal of Infectious Diseases

An evidence-based framework for priority clinical research questions for COVID-19.

Harris C. et al, (2020), Journal of global health, 10

Load More